Skip to main content
Top
Published in: Clinical and Experimental Nephrology 5/2011

01-10-2011 | Original Article

Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis

Authors: Yuan Sun, Yoshihide Fujigaki, Masanori Sakakima, Tomoyuki Fujikura, Akashi Togawa, Yanjie Huang, Akira Hishida

Published in: Clinical and Experimental Nephrology | Issue 5/2011

Login to get access

Abstract

Background

Rats that recovered from mild proximal tubule (PT) injury without renal dysfunction by subtoxic insult, developed partial resistance to subsequent nephrotoxic insult. This partial resistance was associated with reduced renal dysfunction and accelerated PT cell proliferation compared with vehicle treatment as the first insult. Here we assessed the role and potential mechanisms of accelerated PT proliferation in this acquired resistance model.

Methods

Rats at 14 days after recovering from prior mild renal damage induced by 0.2 mg/kg uranyl acetate (UA) (subtoxic dose) were rechallenged with 4 mg/kg UA (nephrotoxic dose) to establish the acquired resistance model. Cell cycle was inhibited by colchicine to examine the contribution of accelerated PT cell proliferation evaluated by in vivo bromodeoxyuridine (BrdU) labeling on acquired resistance to subsequent nephrotoxic insult. Hepatocyte growth factor (HGF)/c-Met axis and other related factors of cell cycle were analyzed.

Results

The acquired resistance to rechallenge injury with nephrotoxic dose of UA in rats recovered from mild renal injury was associated with an earlier increase in BrdU-positive PT cells, accelerated upregulation of HGF mRNA, c-Met mRNA/protein, cyclin D1, phospho-Rb and an earlier phenotypic change of PT cells. Colchicine inhibited PT cell proliferation, reduced the upregulated cyclin D1 and phospho-Rb in the kidney, completely abolishing acquired resistance.

Conclusions

Cell cycle progression with upregulated renal HGF/c-Met axis may contribute to the accelerated recovery from acute renal failure in rats that recovered from prior mild renal damage, followed by nephrotoxic insult, resulting in partial acquired resistance.
Literature
1.
go back to reference Honda N, Hishida A, Ikuma K, Yonemura K. Acquired resistance to acute renal failure. Kidney Int. 1987;31:1233–8.CrossRefPubMed Honda N, Hishida A, Ikuma K, Yonemura K. Acquired resistance to acute renal failure. Kidney Int. 1987;31:1233–8.CrossRefPubMed
2.
go back to reference Furuya R, Kumagai H, Hishida A. Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells. J Lab Clin Med. 1997;129:347–55.CrossRefPubMed Furuya R, Kumagai H, Hishida A. Acquired resistance to rechallenge injury with uranyl acetate in LLC-PK1 cells. J Lab Clin Med. 1997;129:347–55.CrossRefPubMed
3.
go back to reference Zager RA, Burkhart KM, Johnson AC, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and “acquired cytoresistance”. Kidney Int. 1999;56:1788–97.CrossRefPubMed Zager RA, Burkhart KM, Johnson AC, Sacks BM. Increased proximal tubular cholesterol content: implications for cell injury and “acquired cytoresistance”. Kidney Int. 1999;56:1788–97.CrossRefPubMed
4.
go back to reference Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000;58:193–205.CrossRefPubMed Zager RA. Plasma membrane cholesterol: a critical determinant of cellular energetics and tubular resistance to attack. Kidney Int. 2000;58:193–205.CrossRefPubMed
5.
go back to reference Kawaida K, Matsumoto K, Shimazu H, Nakamura K. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–61.CrossRefPubMedPubMedCentral Kawaida K, Matsumoto K, Shimazu H, Nakamura K. Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice. Proc Natl Acad Sci USA. 1994;91:4357–61.CrossRefPubMedPubMedCentral
6.
go back to reference Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–54.CrossRefPubMed Wang Z, Chen JK, Wang SW, Moeckel G, Harris RC. Importance of functional EGF receptors in recovery from acute nephrotoxic injury. J Am Soc Nephrol. 2003;14:3147–54.CrossRefPubMed
7.
go back to reference Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–57.CrossRefPubMed Villegas G, Lange-Sperandio B, Tufro A. Autocrine and paracrine functions of vascular endothelial growth factor (VEGF) in renal tubular epithelial cells. Kidney Int. 2005;67:449–57.CrossRefPubMed
8.
9.
go back to reference Mizuno S, Fujita K, Furuya R, Hishid A, Ito H, Tashim Y, et al. Association of HSP73 with the acquired resistance to uranyl acetate-induced acute renal failure. Toxicology. 1997;117:183–91.CrossRefPubMed Mizuno S, Fujita K, Furuya R, Hishid A, Ito H, Tashim Y, et al. Association of HSP73 with the acquired resistance to uranyl acetate-induced acute renal failure. Toxicology. 1997;117:183–91.CrossRefPubMed
10.
go back to reference Sano K, Fujigaki Y, Miyaji T, Ikegaya N, Ohishi K, Yonemura K, et al. Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate. Kidney Int. 2000;57:1560–70.CrossRefPubMed Sano K, Fujigaki Y, Miyaji T, Ikegaya N, Ohishi K, Yonemura K, et al. Role of apoptosis in uranyl acetate-induced acute renal failure and acquired resistance to uranyl acetate. Kidney Int. 2000;57:1560–70.CrossRefPubMed
11.
go back to reference Ikuma K, Honda N, Hishida A, Nagase M. Loss of glomerular responses to vasoconstrictor agents in rabbits recovering from ARF. Kidney Int. 1986;30:836–41.CrossRefPubMed Ikuma K, Honda N, Hishida A, Nagase M. Loss of glomerular responses to vasoconstrictor agents in rabbits recovering from ARF. Kidney Int. 1986;30:836–41.CrossRefPubMed
12.
go back to reference Sun Y, Fujigaki Y, Sakakima M, Hishida A. Acquired resistance to rechallenge injury in rats recovered from subclinical renal damage with uranyl acetate—importance of proliferative activity of tubular cells. Toxicol Appl Pharmacol. 2010;243:104–10.CrossRefPubMed Sun Y, Fujigaki Y, Sakakima M, Hishida A. Acquired resistance to rechallenge injury in rats recovered from subclinical renal damage with uranyl acetate—importance of proliferative activity of tubular cells. Toxicol Appl Pharmacol. 2010;243:104–10.CrossRefPubMed
13.
go back to reference Mehendale HM, Thakore KN, Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol. 1994;9:131–9.CrossRefPubMed Mehendale HM, Thakore KN, Rao CV. Autoprotection: stimulated tissue repair permits recovery from injury. J Biochem Toxicol. 1994;9:131–9.CrossRefPubMed
14.
go back to reference Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. Role of tissue repair in survival from s-(1, 2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol Sci. 2003;74:215–27.CrossRefPubMed Vaidya VS, Shankar K, Lock EA, Bucci TJ, Mehendale HM. Role of tissue repair in survival from s-(1, 2-dichlorovinyl)-l-cysteine-induced acute renal tubular necrosis in the mouse. Toxicol Sci. 2003;74:215–27.CrossRefPubMed
15.
go back to reference Korrapati MC, Chilakapati J, Lock EA, Latendresse JR, Warbritton A, Mehendale HM. Preplaced cell division: a critical mechanism of autoprotection against S-1, 2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am J Physiol Renal Physiol. 2006;291:F439–55.CrossRefPubMed Korrapati MC, Chilakapati J, Lock EA, Latendresse JR, Warbritton A, Mehendale HM. Preplaced cell division: a critical mechanism of autoprotection against S-1, 2-dichlorovinyl-l-cysteine-induced acute renal failure and death in mice. Am J Physiol Renal Physiol. 2006;291:F439–55.CrossRefPubMed
16.
go back to reference Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, et al. Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant. 2009;24:2686–92.CrossRefPubMed Fujigaki Y, Sakakima M, Sun Y, Fujikura T, Tsuji T, Yasuda H, et al. Cell division and phenotypic regression of proximal tubular cells in response to uranyl acetate insult in rats. Nephrol Dial Transplant. 2009;24:2686–92.CrossRefPubMed
17.
go back to reference Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.CrossRefPubMed Matsumoto K, Nakamura T. Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 2001;59:2023–38.CrossRefPubMed
18.
go back to reference Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–53.CrossRefPubMed Liu Y, Tolbert EM, Lin L, Thursby MA, Sun AM, Nakamura T, et al. Up-regulation of hepatocyte growth factor receptor: an amplification and targeting mechanism for hepatocyte growth factor action in acute renal failure. Kidney Int. 1999;55:442–53.CrossRefPubMed
19.
go back to reference Rao VC, Mehendale HM. Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol. 1993;67:392–400.CrossRefPubMed Rao VC, Mehendale HM. Effect of antimitotic agent colchicine on carbon tetrachloride toxicity. Arch Toxicol. 1993;67:392–400.CrossRefPubMed
20.
go back to reference Dalu A, Rao PS, Mehendale HM. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality. Environ Health Perspect. 1998;106:597–606.CrossRefPubMedPubMedCentral Dalu A, Rao PS, Mehendale HM. Colchicine antimitosis abolishes resiliency of postnatally developing rats to chlordecone-amplified carbon tetrachloride hepatotoxicity and lethality. Environ Health Perspect. 1998;106:597–606.CrossRefPubMedPubMedCentral
21.
go back to reference Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23:2198–205.CrossRefPubMed Luo J, Tsuji T, Yasuda H, Sun Y, Fujigaki Y, Hishida A. The molecular mechanisms of the attenuation of cisplatin-induced acute renal failure by N-acetylcysteine in rats. Nephrol Dial Transplant. 2008;23:2198–205.CrossRefPubMed
22.
go back to reference Qiu J, Liu Z, Da L, Li Y, Xuan H, Lin Q, et al. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4. J Hepatol. 2007;46:266–75.CrossRefPubMed Qiu J, Liu Z, Da L, Li Y, Xuan H, Lin Q, et al. Overexpression of the gene for transmembrane 4 superfamily member 4 accelerates liver damage in rats treated with CCl4. J Hepatol. 2007;46:266–75.CrossRefPubMed
23.
go back to reference Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, et al. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med. 2006;17:857–64.PubMed Inoue H, Yokoyama F, Kita Y, Yoshiji H, Tsujimoto T, Deguchi A, et al. Relationship between the proliferative capability of hepatocytes and the intrahepatic expression of hepatocyte growth factor and c-Met in the course of cirrhosis development in rats. Int J Mol Med. 2006;17:857–64.PubMed
24.
go back to reference Del Signore A, De Sanctis V, Di Mauro E, Negri R, Perrone-Capano C, Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J Neurosci. 2006;23:65–74.CrossRefPubMed Del Signore A, De Sanctis V, Di Mauro E, Negri R, Perrone-Capano C, Paggi P. Gene expression pathways induced by axotomy and decentralization of rat superior cervical ganglion neurons. Eur J Neurosci. 2006;23:65–74.CrossRefPubMed
25.
go back to reference Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, et al. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. 2006;21:41–50.CrossRefPubMed Fujigaki Y, Goto T, Sakakima M, Fukasawa H, Miyaji T, Yamamoto T, et al. Kinetics and characterization of initially regenerating proximal tubules in S3 segment in response to various degrees of acute tubular injury. Nephrol Dial Transplant. 2006;21:41–50.CrossRefPubMed
26.
go back to reference Li C, Yang CW, Ahn HJ, Kim WY, Park CW, Park JH, et al. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Nephron. 2002;92:422–30.CrossRefPubMed Li C, Yang CW, Ahn HJ, Kim WY, Park CW, Park JH, et al. Colchicine suppresses osteopontin expression and inflammatory cell infiltration in chronic cyclosporine nephrotoxicity. Nephron. 2002;92:422–30.CrossRefPubMed
27.
go back to reference Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;297:F200–9.CrossRefPubMed Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, et al. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Am J Physiol Renal Physiol. 2009;297:F200–9.CrossRefPubMed
28.
go back to reference Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258–61.CrossRefPubMed Terada Y, Inoshita S, Nakashima O, Kuwahara M, Sasaki S, Marumo F. Regulation of cyclin D1 expression and cell cycle progression by mitogen-activated protein kinase cascade. Kidney Int. 1999;56:1258–61.CrossRefPubMed
29.
go back to reference Seville LL, Shah N, Westwell AD, Chan WC. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets. 2005;5:159–70.CrossRefPubMed Seville LL, Shah N, Westwell AD, Chan WC. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr Cancer Drug Targets. 2005;5:159–70.CrossRefPubMed
30.
go back to reference Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol. 2001;280:F562–73.CrossRefPubMed Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol. 2001;280:F562–73.CrossRefPubMed
31.
go back to reference Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93:2175–88.CrossRefPubMedPubMedCentral Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-fos, and clusterin in the post-ischemic kidney. Evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest. 1994;93:2175–88.CrossRefPubMedPubMedCentral
32.
go back to reference Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol. 2006;290:R861–70.CrossRefPubMed Villanueva S, Céspedes C, Vio CP. Ischemic acute renal failure induces the expression of a wide range of nephrogenic proteins. Am J Physiol Regul Integr Comp Physiol. 2006;290:R861–70.CrossRefPubMed
34.
go back to reference Imai E, Isaka Y. Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens. 2002;11:49–57.CrossRefPubMed Imai E, Isaka Y. Targeting growth factors to the kidney: myth or reality? Curr Opin Nephrol Hypertens. 2002;11:49–57.CrossRefPubMed
35.
go back to reference Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol. 2001;12:531–40.PubMed Rabkin R, Fervenza F, Tsao T, Sibley R, Friedlaender M, Hsu F, et al. Hepatocyte growth factor receptor in acute tubular necrosis. J Am Soc Nephrol. 2001;12:531–40.PubMed
36.
go back to reference Tajima H, Higuchi O, Mizuno K, Nakamura T. Tissue distribution of hepatocyte growth factor receptor and its exclusive downregulation in a regenerating organ after injury. J Biochem. 1992;111:401–6.CrossRefPubMed Tajima H, Higuchi O, Mizuno K, Nakamura T. Tissue distribution of hepatocyte growth factor receptor and its exclusive downregulation in a regenerating organ after injury. J Biochem. 1992;111:401–6.CrossRefPubMed
37.
go back to reference Leshem Y, Halevy O. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent. J Cell Physiol. 2002;191:173–82.CrossRefPubMed Leshem Y, Halevy O. Phosphorylation of pRb is required for HGF-induced muscle cell proliferation and is p27kip1-dependent. J Cell Physiol. 2002;191:173–82.CrossRefPubMed
Metadata
Title
Acquired resistance to rechallenge injury in rats that recovered from mild renal damage induced by uranyl acetate: accelerated proliferation and hepatocyte growth factor/c-Met axis
Authors
Yuan Sun
Yoshihide Fujigaki
Masanori Sakakima
Tomoyuki Fujikura
Akashi Togawa
Yanjie Huang
Akira Hishida
Publication date
01-10-2011
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 5/2011
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-011-0453-x

Other articles of this Issue 5/2011

Clinical and Experimental Nephrology 5/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.